Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PLA2G7 | Q13093 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.30 |
| ▸ | TYR | P14679 | 2/20 | 0.30 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.30 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10319805 | 0.82 | LMNA (0.43) | ABL1PDGFRATDP1PLA2G7HSD17B1 | |
| SCHEMBL30105652 | 0.82 | LMNA (0.43) | ABL1PDGFRATDP1PLA2G7HSD17B1 | |
| SCHEMBL10415156 | 0.81 | ALDH1A1 (0.42) | ABL1PDGFRAALDH1A1POLBAPEX1 | |
| SCHEMBL8821558 | 0.78 | ABL1 (0.33) | ABL1PDGFRA | |
| SCHEMBL5711157 | 0.76 | ABL1 (0.32) | ABL1PDGFRA | |
| SCHEMBL18888856 | 0.74 | PLA2G7 (0.51) | ABL1PDGFRAALDH1A1PLA2G7LMNA | |
| SCHEMBL12439598 | 0.73 | ERN1 (0.40) | ERN1TYRTRIM24TRIM33 | |
| SCHEMBL10415167 | 0.71 | PTGS1 (0.38) | ALDH1A1POLBL3MBTL1ERN1HSD17B1 | |
| SCHEMBL18889770 | 0.70 | ACHE (0.42) | ABL1PDGFRAPLA2G7TSHRHSD17B1 | |
| SCHEMBL14260677 | 0.70 | ERN1 (0.50) | ERN1TRIM24TRIM33 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075455-A | Application of Lactarius delin Lactaroviolin in preparation of products for treating MASLD | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075455-A | Application of Lactarius delin Lactaroviolin in preparation of products for treating MASLD | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122075455-A | Application of Lactarius delin Lactaroviolin in preparation of products for treating MASLD | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122075455-A | Application of Lactarius delin Lactaroviolin in preparation of products for treating MASLD | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250360073-A1 | SOLUBILIZING PIGMENTS EXTRACTED FROM FUNGI FOR APPLICATIONS SUCH AS COSMETIC PRODUCTS | ADLER JESSE (US) | 2025-11-27 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-6291702-B1 | AS AGENTS FOR TRAPPING AND IDENTIFYING FREE RADICAL SPECIES AND FIND USE AS EFFICIENT ANTIOXIDANTS IN PHYSICOCHEMICAL AND BIOLOGICAL SYSTEMS. | FLORIDA INTERNATIONAL UNIVERSITY | 2001-09-18 | — | — | US | disclosed |
| US-6197825-B1 | EFFECTIVE AGENTS FOR TRAPPING AND IDENTIFYING FREE RADICAL SPECIES AND FIND USE AS EFFICIENT ANTIOXIDANTS IN PHYSICOCHEMICAL AND BIOLOGICAL SYSTEMS. DIAMAGNETIC NITRONE COMPOUND (THE ?SPIN TRAP?) REACTS WITH A TRANSIENT FREE | FLORIDA INTERNATIONAL UNIVERSITY | 2001-03-06 | — | — | US | disclosed |
| US-6083988-A | AZULENYL NITRONES ARE EFFECTIVE AGENTS FOR TRAPPING AND IDENTIFYING FREE RADICALS AND FIND USE AS EFFICIENT ANTIOXIDANT IN PHYSICOCHEMICAL AND BIOLOGICAL SYSTEMS | FLORIDA INTERNATIONAL UNIVERSITY | 2000-07-04 | — | — | US | disclosed |
| EP-0888290-A1 | AZULENYL NITRONE SPIN TRAPPING AGENTS, METHODS OF MAKING AND USING SAME | Florida International University (US) | 1999-01-07 | — | — | EP | disclosed |
| US-5696171-A | Contact lens disinfecting compositions and methods employing terpenes | ALLERGAN, INC. (US) | 1997-12-09 | — | — | US | disclosed |
| WO-1997019054-A9 | AZULENYL NITRONE SPIN TRAPPING AGENTS, METHODS OF MAKING AND USING SAME | — | 1997-08-07 | — | — | WO | disclosed |
| EP-0778782-A1 | CONTACT LENS DISINFECTING COMPOSITIONS AND METHODS EMPLOYING TERPENES | Allergan (US) | 1997-06-18 | — | — | EP | disclosed |
| WO-1997019054-A1 | AZULENYL NITRONE SPIN TRAPPING AGENTS, METHODS OF MAKING AND USING SAME | FLORIDA INTERNATIONAL UNIVERSITY (US) | 1997-05-29 | — | — | WO | disclosed |
| WO-1996006644-A1 | CONTACT LENS DISINFECTING COMPOSITIONS AND METHODS EMPLOYING TERPENES | ALLERGAN, INC. (US) | 1996-03-07 | — | — | WO | disclosed |
| US-4086216-A | Glycoprotein extracted from the mushroom psalliota xanthoderma and its application in anti-viral therapy | Centre Europeen de Recherches Mauvernay "C.E.R.M." (FR) | 1978-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | ABL1 3046/4885PDGFRA 1036/4885ALDH1A1 1420/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | ABL1 3527/4885PDGFRA 416/4885ALDH1A1 4768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.